This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Negative Symptoms of Schizophrenia Are Improved by Paroxetine Added to Neuroleptics: A Pilot Study

Maria C. Jockers-Scherübl, Frank Godemann, and Adolf Pietzcker

Published: July 1, 2001

Article Abstract

Letter to the Editor

Sir: Conventional antipsychotic drugs are highly effective in alleviating positive symptoms in schizophrenia, but they have little impact on primary negative symptoms such as apathy, social withdrawal, blunted affect, and motor retardation. Atypical neuroleptics could only bridge part of this treatment gap. In the 1970s, tricyclic and tetracyclic antidepressants were added to antipsychotic treatment in chronic schizophrenia, but none improved negative symptoms consistently. Since the early 1990s, selective serotonin reuptake inhibitors such as fluvoxamine and fluoxetine have been added to neuroleptic treatment strategies on the assumption that negative symptoms might be associated with serotonergic dysfunction.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: